Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04928170Active Not Recruiting

The Halland Osteoarthritis Cohort

Role: collaborator

NCT05815381Completed

Autoimmune Mechanisms in Fibromyalgia

Role: collaborator

NCT02022566Not ApplicableCompleted

Effect of Structured Info and Adapted Exercise in OA

Role: collaborator

NCT01992770Not ApplicableTerminated

A Stepped-care Model of Tailored Behavioural Medicine Pain Intervention in Primary Care

Role: collaborator

NCT01270087Phase 4Completed

The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study.

Role: collaborator

NCT00803491Not ApplicableUnknown

Health Related Quality of Life After a Self-promoting Learning Program for People With Rheumatic Diseases

Role: collaborator

NCT01071447Not ApplicableUnknown

Nurse-led Clinic for Patients With Rheumatic Diseases and Biological Treatment

Role: collaborator

All 7 trials loaded